Skip to content

Adequacy of Pain Treatment in Radiotherapy

Adequacy of Pain Treatment in Radiotherapy: an Observational, Prospective, Multicenter Study (ARISE)

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03550599
Enrollment
2000
Registered
2018-06-08
Start date
2018-03-01
Completion date
2019-06-01
Last updated
2019-01-14

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Analgesic Drugs, Cancer Pain

Brief summary

Aim of the study is to evaluate adequacy of pain treatment in oncologic patients, accessing to Radiotherapy Unit

Detailed description

Prescription of analgesic drugs is a basic topic in cancer patients, but undertreatment is common. The aim of the study is to analyse pain control and adequacy of antalgic treatments in patients coming to Radiotherapy Unit for radiation treatment.

Interventions

OTHERPatients accessing to Radiotherapy Unit

No intervention; information about patient and disease characteristics will be recorded as well as information about pain and analgesic treatment

Sponsors

IRCCS Azienda Ospedaliero-Universitaria di Bologna
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

\- patients accessing to Radiotherapy Unit for radiation treatment (both palliative or with radical intent) with diagnosis of primitive or metastatic cancer;

Exclusion criteria

\- Concomitant diseases that can affect reliability of collected data

Design outcomes

Primary

MeasureTime frameDescription
Evaluation of adequacy of pain treatment2 monthsFor all patients, Visual Analogue Scale (VAS) and information about type of analgesic drugs (no drugs; non-opioid drugs; weak opioids; strong opioids) will be recorded and analysed

Countries

Italy

Contacts

Primary ContactAlessio G Morganti, MD
alessio.morganti2@unibo.it0512143564

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026